BioSpace News Archive

Business

Intelligent Bio Solutions Signs South American Distribution Agreement with TSCOM for Fingerprint Drug Screening System and Secures First Order

Intelligent Bio Solutions Inc. today announced it has signed a distribution agreement for its Intelligent Fingerprinting Drug Screening System with Chile-based company TSCOM SPA , increasing the product’s availability across South America.

July 6, 2023
·
5 min read
Business

Charles River Associates (CRA) Expands Its Life Sciences Practice - July 6, 2023

Charles River Associates today announced that Sheldon Ng has joined the company’s Life Sciences Practice as a vice president.

July 6, 2023
·
4 min read
Business

Dexcom Schedules Second Quarter 2023 Earnings Release and Conference Call for July 27, 2023 at 4:30 p.m. Eastern Time

DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its second quarter 2023 financial results after market close on Thursday, July 27, 2023.

July 6, 2023
·
1 min read
Business

Modular Medical Announces Diabetes Industry Veteran Duane DeSisto Will Join the Board of Directors

Modular Medical, Inc. today announced the appointment of medical device industry leader Duane DeSisto to its board of directors.

July 6, 2023
·
4 min read
Pharm Country

3D Screen Printing Technology Enables Fabrication of Oral Dosage Forms with Freely Tailorable Drug Release Profiles – Technology and Concept Well Suited for Mass Production

A study published in the International Journal of Pharmaceutics explores the advancement of pharmaceutical oral dosage forms and the feasibility of manufacturing composite tablets with freely tailorable drug release profiles using 3D screen printing (3DSP) technology.

July 6, 2023
·
3 min read
Business

Flash Therapeutics Appoints Jérôme Bédier as President to Accelerate its Biopharmaceutical CDMO Business Development

Flash Therapeutics, the French specialist in the design and bioproduction of lentiviral vectors for the transfer of DNA and RNA genetic material for its biotech customers in gene, cell, RNA and vaccine therapies, today announced the appointment of Jérôme Bédier as President.

July 6, 2023
·
3 min read
FDA

Inovedis Receives FDA Clearance of the SINEFIX™ Implant System for Rotator Cuff Repair

Inovedis GmbH today announced that it has received clearance from the U.S. Food and Drug Administration (FDA) for SINEFIX™, a new implant system for the repair of rotator cuff tears.

July 6, 2023
·
3 min read
Deals

VBI Vaccines Announces Pricing of $18 Million Public Offering and $3 Million Concurrent Registered Direct Offering

VBI Vaccines Inc. today announced the pricing of its previously announced underwritten public offering of 10,909,091 common shares.

July 6, 2023
·
8 min read
Business

Tempus Announces Companion Diagnostic Collaboration with TScan Therapeutics

Tempus today announced a new collaboration to develop a companion diagnostic (CDx) test with TScan Therapeutics, a clinical-stage biopharmaceutical company focused on the development of T cell receptor (TCR)-engineered T cell therapies (TCR-T) for the treatment of cancer patients.

July 6, 2023
·
6 min read
Biotech Beach

United States Adopted Name (USAN) Council and INN Expert Committee Recognizes New Therapeutic Class by Granting “nibrozetone” as New Generic Name for EpicentRx’s Lead Small Molecule NLRP3 Inhibitor, RRx-001

EpicentRx, Inc. announced that the United States Adopted Name Council in consultation with the World Health Organization’s International Nonproprietary Names Expert Committee has assigned the generic name “nibrozetone”, a shortening of the chemical name, alpha-bromodinitroazetidine, for its lead drug candidate, RRx-001.

July 6, 2023
·
3 min read